Clearing clinical and regulatory hurdles in the development of a fast-acting nasal spray for a heart condition has been a ...

With this funding, Entvin plans to expand its artificial intelligence capabilities and accelerate customer acquisition ...

SeaStar Medical Fourth Quarter and Year-End 2024 Financial Results Conference Call A replay of the call will be available after 7:30 pm ET and can be accessed as follows: The webcast replay is ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Here's how Central Florida health care providers and experts are navigating the delicate balance between medical AI ...

Shares of Tonix Pharmaceuticals are pulling back 12.7% during Thursday's session. The stock is pulling back following a regulatory update on its experimental fibromyalgia treatment, TNX-102 SL.

A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...

The FDA launches sweeping changes to food safety rules that could transform grocery aisles nationwide as untested ingredients ...

Trump’s picks for top health jobs have criticized the organizations they will run, as well as the federal response to the ...

Switzerland is working toward reestablishing its relationship with the EU while exploring new avenues. Meanwhile, the U.K. is ...

Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.

Low doses of a drug already approved for treating rare genetic conditions in humans kills mosquitoes dead. Scientists say it ...